Status of Surgical Management of Borderline Ovarian Tumors in France: are Recommendations Being Followed? Multicentric French Study by the FRANCOGYN Group.

Date publication

avril 2021

Journal

Annals of surgical oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr COUTANT Charles , Dr DEMARCHI Martin , Dr GANTZER Justine , Pr AKLADIOS Chérif

Tous les auteurs :
Lecointre L, Bund V, Sangnier E, Ouldamer L, Bendifallah S, Koskas M, Bolze PA, Collinet P, Canlorbe G, Touboul C, Huchon C, Coutant C, Faller E, Boisramé T, Gantzer J, Demarchi M, Lavoué V, Akladios C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/33904003

Résumé

Borderline ovarian tumors (BOTs) are tumors with a favorable prognosis but whose management by consensus is essential to limit the risk of invasive recurrence. This study aimed to conduct an inventory of surgical practices for BOT in France and to evaluate the conformity of the treatment according to the current French guidelines.

Référence

Ann Surg Oncol. 2021 Apr 26;: